Ask AI

ART Selection in the Setting of Weight Gain

Case Challenge
Case Challenge Start Activity
This activity is available for 0.50 CME/CE credit(s).

Released: August 28, 2026

Expiration: August 27, 2027

See Activity Collection

People living with HIV starting antiretroviral therapy (ART) often gain weight, and certain antiretroviral drugs are associated with more weight gain than others. Learn how to address this using this AI-adaptive case that leverages PRISM-ID, a Johns Hopkins–designed custom AI learning agent for HIV medicine, which features personalized, adaptive educational case scenarios. 

ART and Weight Gain

Pre Assessment: Prepare to Meet Your Patient

Assess your current knowledge and clinical approach before meeting your patient.
1.

How many people living with HIV do you provide care for in a typical week?

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

Following weight gain on dolutegravir (DTG) + emtricitabine (FTC)/tenofovir alafenamide (TAF) and a new diagnosis of hepatic steatosis, would you change the antiretroviral therapy (ART) regimen?